[1]
|
中华医学会感染病学分会艾滋病丙肝学组, 中国疾病预防与控制中心. 中国艾滋病诊疗指南(2021年版) [J]. 中华临床感染病杂志, 2021, 14(5): 321-343.
|
[2]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021(4): 315-409.
|
[3]
|
Ortíz, D.W., Marroquin, H.E., Larson, L., et al. (2022) Metabolic Syn-drome in People with HIV from Guatemala: Analysis of Components and Risk Factors. International Journal of STD & AIDS, 33, 987-994.
https://doi.org/10.1177/09564624221119321
|
[4]
|
Savinelli, S., Wrigley, K.N., Feeney, E.R., et al. (2022) Obesity in HIV Infection: Host-Pathogen Interaction. AIDS, 36, 1477-1491. https://doi.org/10.1097/QAD.0000000000003281
|
[5]
|
Pantazis, N., Papastamopoulos, V., Antoniadou, A., et al. (2022) Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug. Vi-ruses, 14, Article No. 1677.
https://doi.org/10.3390/v14081677
|
[6]
|
Han, W.M., Law, M.G., Choi, J.Y., et al. (2022) Weight Changes, Meta-bolic Syndrome and All-Cause Mortality among Asian Adults Living with HIV. HIV Medicine, 23, 274-286. https://doi.org/10.1111/hiv.13211
|
[7]
|
Khuon, D., Rupasinghe, D., Saphonn, V., et al. (2023) BMI as a Predictor of High Fasting Blood Glucose among People Living with HIV in the Asia-Pacific Region. HIV Medicine, 24, 139-152. https://doi.org/10.1111/hiv.13351
|
[8]
|
Gómez-Ayerbe, C., Palacios, R., Mayorga, M., et al. (2022) Weight Changes after First-Line Antiretroviral Initiation in a Cohort of HIV-Positive Patients in Southern Spain (CAPOTA Study). International Journal of STD & AIDS, 33, 1119-1123. https://doi.org/10.1177/09564624221125356
|
[9]
|
Castro, A.C., Silveira, E.A., Falco, M.O., et al. (2016) Over-weight and Abdominal Obesity in Adults Living with HIV/AIDS. Revista da Associação Médica Brasileira (1992), 62, 353-360.
https://doi.org/10.1590/1806-9282.62.04.353
|
[10]
|
Sax, P.E., Erlandson, K.M., Lake, J.E., et al. (2020) Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials. Clinical Infectious Diseases, 71, 1379-1389.
https://doi.org/10.1093/cid/ciz999
|
[11]
|
Chihota, B.V., Mandiriri, A., Shamu, T., et al. (2022) Metabolic Syndrome among Treatment-Naïve People Living with and without HIV in Zambia and Zimbabwe: A Cross-Sectional Analysis. Journal of the International AIDS Society, 25, e26047. https://doi.org/10.1002/jia2.26047
|
[12]
|
Bailin, S.S. and Koethe, J.R. (2023) Diabetes in HIV: The Link to Weight Gain. Current HIV/AIDS Reports, 20, 9-18.
https://doi.org/10.1007/s11904-022-00642-w
|
[13]
|
Borkowska, T., Chkhartishvili, N., Karkashadze, E., et al. (2022) The Prevalence of Hyperglycemia and Its Impact on Mortality among People Living with HIV in Georgia. PLOS ONE, 17, e276749.
https://doi.org/10.1371/journal.pone.0276749
|
[14]
|
Slama, L., Barrett, B.W., Abraham, A.G., et al. (2021) Risk for Incident Diabetes Is Greater in Prediabetic Men with HIV than without HIV. AIDS, 35, 1605-1614. https://doi.org/10.1097/QAD.0000000000002922
|
[15]
|
Isa, S.E., Oche, A.O., Kang’Ombe, A.R., et al. (2016) Human Immunodeficiency Virus and Risk of Type 2 Diabetes in a Large Adult Cohort in Jos, Nigeria. Clinical Infectious Diseases, 63, 830-835. https://doi.org/10.1093/cid/ciw381
|
[16]
|
Buendia, J.R., Sears, S., Griffin, E., et al. (2022) Prevalence and Risk Factors of Type II Diabetes Mellitus among People Living with HIV in Texas. AIDS Care, 34, 900-907. https://doi.org/10.1080/09540121.2021.1925212
|
[17]
|
Shen, Y., Wang, Z., Liu, L., et al. (2013) Preva-lence of Hyperglycemia among Adults with Newly Diagnosed HIV/AIDS in China. BMC Infectious Diseases, 13, Arti-cle No. 79. https://doi.org/10.1186/1471-2334-13-79
|
[18]
|
Xu, Y., Chen, X. and Wang, K. (2017) Global Preva-lence of Hypertension among People Living with HIV: A Systematic Review and Meta-Analysis. Journal of the Ameri-can Society of Hypertension, 11, 530-540.
https://doi.org/10.1016/j.jash.2017.06.004
|
[19]
|
Mills, K.T., Bundy, J.D., Kelly, T.N., et al. (2016) Global Dispari-ties of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies from 90 Countries. Circulation, 134, 441-450.
https://doi.org/10.1161/CIRCULATIONAHA.115.018912
|
[20]
|
Davis, K., Moorhouse, L., Maswera, R., et al. (2023) Associations between HIV Status and Self-Reported Hypertension in a High HIV Prevalence Sub-Saharan Afri-can Population: A Cross-Sectional Study. BMJ Open, 13, e67327.
https://doi.org/10.1136/bmjopen-2022-067327
|
[21]
|
Isa, S.E., Kang’Ombe, A.R., Simji, G.S., et al. (2017) Hyper-tension in Treated and Untreated Patients with HIV: A Study from 2011 to 2013 at the Jos University Teaching Hospital, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 111, 172-177. https://doi.org/10.1093/trstmh/trx030
|
[22]
|
Chang, D., Esber, A., Dear, N., et al. (2022) Non-Communicable Dis-eases in Older People Living with HIV in Four African Countries: A Cohort Study. The Lancet HIV, 9, S5. https://doi.org/10.1016/S2352-3018(22)00070-4
|
[23]
|
Sadinski, L.M., Westreich, D., Edmonds, A., et al. (2023) Hypertension and One-Year Risk of All-Cause Mortality among Women with Treated HIV in the United States. AIDS, 37, 679-688.
https://doi.org/10.1097/QAD.0000000000003461
|
[24]
|
Xu, X., Chen, X., Lin, H., et al. (2021) General and Ab-dominal Obesity and Incident Hypertension among People Living with HIV on Antiretroviral Therapy. AIDS Care, 33, 1616-1620. https://doi.org/10.1080/09540121.2020.1852158
|
[25]
|
Remch, M., Franceschini, N., Davy-Mendez, T., et al. (2022) Hypertension Burden, Treatment, and Control among People with HIV at a Clinical Care Center in the Southeastern US, 2014-2019. AIDS Care, 1-10.
https://doi.org/10.1080/09540121.2022.2148626
|
[26]
|
Duan, Y., Zhao, H., Tang, W., et al. (2022) Longitudinal Analysis of New-Onset Non-AIDS-Defining Diseases among People Living with HIV: A Real-World Observational Study. HIV Medicine, 23, 32-41.
https://doi.org/10.1111/hiv.13247
|
[27]
|
Yang, C., Wang, D., Ma, Y., et al. (2022) Effectors of Hyperlipidemia among HIV/AIDS Patients with Second-Line Antiretroviral Therapy Based on Register Data. Current HIV Research, 20, 373-379.
https://doi.org/10.2174/1570162X20666220805103411
|
[28]
|
Buendia, J., Sears, S. and Mgbere, O. (2022) Preva-lence and Risk Factors of High Cholesterol and Triglycerides among People with HIV in Texas. AIDS Research and Therapy, 19, Article No. 43.
https://doi.org/10.1186/s12981-022-00467-y
|
[29]
|
Ojong, E., Iya, B., Djeufouata, J., et al. (2022) Metabolic Syn-drome and Its Components among HIV/AIDS Patients on Antiretroviral Therapy and ART-Naïve Patients at the Univer-sity of Calabar Teaching Hospital, Calabar, Nigeria. African Health Sciences, 22, 410-417. https://doi.org/10.4314/ahs.v22i1.50
|
[30]
|
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486-2497.
https://doi.org/10.1001/jama.285.19.2486
|
[31]
|
Alberti, K.G., Zimmet, P. and Shaw, J. (2005) The Metabolic Syn-drome—A New Worldwide Definition. The Lancet, 366, 1059-1062. https://doi.org/10.1016/S0140-6736(05)67402-8
|
[32]
|
Møller, S.P., Amare, H., Christensen, D.L., et al. (2020) HIV and Metabolic Syndrome in an Ethiopian Population. Annals of Human Biology, 47, 457-464. https://doi.org/10.1080/03014460.2020.1781929
|
[33]
|
Aurpibul, L., Namwongprom, S., Sudjaritruk, T., et al. (2020) Metabolic Syndrome, Biochemical Markers, and Body Composition in Youth Living with Perinatal HIV Infection on Antiretroviral Treatment. PLOS ONE, 15, e230707.
https://doi.org/10.1371/journal.pone.0230707
|